$1.61
-0.05-3.01%
At close: Dec 15, 4:00 PM EST
$1.61
N/A
After Hours: 4:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Akebia Therapeutics Insider Trading Activity
AKBANASDAQ
Akebia Therapeutics Insider Trading Activity | NASDAQ:AKBA | Benzinga
Track the latest Akebia Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Akebia Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Akebia Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Akebia Therapeutics Inc
Shares Outstanding
265.366M
Insider Shares Owned
9.153M
Insider Percentage Owned
3.45%
Institutional Shares Held
76.099M
Institutional Percentage Held
28.7%
| Jul 01, 2025 | Erik Ostrowski | SVP, CFO, CBO & TREASURER | -41.31K | $3.67 | -$151.62K | SELL | -7.58% | 503.59K | Jun 30 | View |
| Jun 11, 2025 | Richard C Malabre | SVP, CHIEF ACCOUNTING OFFICER | 0.00 | $2.84 | -$34.95K | SELL-OPTIONS | 0.00% | 266.91K | Jun 09 | View |
| Jun 05, 2025 | Richard C Malabre | SVP, CHIEF ACCOUNTING OFFICER | -13.33K | $3.53 | -$47.07K | SELL | -4.76% | 266.91K | Jun 04 | View |
| Mar 04, 2025 | John P Butler | CEO AND PRESIDENT | -46.41K | $1.83 | -$84.93K | SELL | -1.74% | 2.62M | Mar 03 | View |
| Mar 04, 2025 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.14K | $1.83 | -$13.07K | SELL | -0.88% | 809.09K | Mar 03 | View |
| Feb 04, 2025 | John P Butler | CEO AND PRESIDENT | 556.75K | $2.10 | -$302.93K | GRANT | 26.42% | 2.66M | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 144.39K | $2.10 | -$106.06K | GRANT | 21.49% | 816.23K | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Richard C Malabre | SVP, CHIEF ACCOUNTING OFFICER | 54.80K | $2.10 | -$63.42K | GRANT | 24.31% | 280.25K | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Nicholas Grund | CHIEF COMMERCIAL OFFICER | 139.28K | $2.10 | -$116.80K | GRANT | 45.92% | 442.58K | Jan 31 - Feb 03 | View |
| May 14, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -12.02K | $1.26 | -$15.14K | SELL | -1.81% | 651.24K | May 13 | View |
| May 14, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -34.84K | $1.26 | -$43.90K | SELL | -4.93% | 672.09K | May 13 | View |
| May 09, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -27.00K | $1.15 | -$31.05K | SELL | -3.88% | 668.84K | Aug 25 | View |
| Mar 01, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -8.66K | $1.58 | -$13.68K | SELL | -1.21% | 706.93K | Feb 29 | View |
| Mar 01, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -5.97K | $1.58 | -$9.44K | SELL | -0.89% | 663.26K | Feb 29 | View |
| Mar 01, 2024 | John P Butler | CEO AND PRESIDENT | -46.57K | $1.58 | -$73.58K | SELL | -2.16% | 2.10M | Feb 29 | View |
| Mar 01, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.17K | $1.58 | -$11.33K | SELL | -1.02% | 695.84K | Feb 29 | View |
| Feb 29, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -7.41K | $1.52 | -$11.26K | SELL | -1.10% | 669.23K | Feb 27 | View |
| Feb 29, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.74K | $1.52 | -$16.33K | SELL | -1.48% | 715.59K | Feb 27 | View |
| Feb 29, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -8.37K | $1.52 | -$12.72K | SELL | -1.18% | 703.01K | Feb 27 | View |
| Feb 29, 2024 | John P Butler | CEO AND PRESIDENT | -37.73K | $1.52 | -$57.35K | SELL | -1.72% | 2.15M | Feb 27 | View |
| Feb 02, 2024 | John P Butler | CEO AND PRESIDENT | 557.01K | $1.68 | -$78.10K | GRANT | 34.13% | 2.19M | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 177.89K | $1.68 | -$40.84K | GRANT | 33.34% | 711.38K | Jan 31 - Feb 01 | View |
| May 25, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 136.81K | $1.22 | -$77.27K | GRANT | 35.30% | 524.34K | May 24 - May 25 | View |
| May 25, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 104.52K | $1.22 | -$116.76K | GRANT | 22.26% | 574.04K | May 24 - May 25 | View |
| May 18, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -63.57K | $1.07 | -$67.89K | SELL | -10.70% | 530.49K | May 16 | View |
| May 18, 2023 | David A Spellman | SVP, CFO AND TREASURER | -63.57K | $1.07 | -$67.89K | SELL | -12.46% | 446.48K | May 16 | View |
| Mar 03, 2023 | John P Butler | CEO AND PRESIDENT | -91.87K | $0.88 | -$80.61K | SELL | -5.34% | 1.63M | Mar 01 | View |
| Mar 03, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -13.03K | $0.88 | -$11.44K | SELL | -4.34% | 287.53K | Mar 01 | View |
| Mar 03, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -14.12K | $0.88 | -$12.39K | SELL | -2.32% | 594.05K | Mar 01 | View |
| Mar 03, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -20.41K | $0.88 | -$17.91K | SELL | -7.04% | 269.51K | Mar 01 | View |
| Mar 03, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.21K | $0.88 | -$6.33K | SELL | -1.39% | 510.05K | Mar 01 | View |
| Mar 01, 2023 | John P Butler | CEO AND PRESIDENT | -38.63K | $0.81 | -$31.42K | SELL | -2.20% | 1.72M | Feb 27 | View |
| Mar 01, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.54K | $0.81 | -$6.13K | SELL | -1.22% | 608.18K | Feb 27 | View |
| Mar 01, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.09K | $0.81 | -$8.21K | SELL | -3.36% | 289.93K | Feb 27 | View |
| Mar 01, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.54K | $0.81 | -$6.13K | SELL | -1.44% | 517.26K | Feb 27 | View |
| Mar 01, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -6.68K | $0.81 | -$5.43K | SELL | -2.17% | 300.56K | Feb 27 | View |
| Sep 01, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.15K | $0.36 | -$415.79 | SELL | -0.27% | 418.02K | Aug 31 | View |
| Jun 07, 2022 | Steven C Gilman | — | -4.57K | $0.36 | -$1.65K | SELL | -9.52% | 43.43K | Jun 03 | View |
| Mar 02, 2022 | John P Butler | CEO AND PRESIDENT | 214.10K | $2.17 | -$171.14K | GRANT | 16.61% | 1.50M | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 44.94K | $2.16 | -$32.56K | GRANT | 26.02% | 217.66K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | 36.89K | $2.15 | -$8.50K | GRANT | 111.55% | 69.95K | Feb 28 | View |
| Mar 02, 2022 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 28.47K | $2.17 | -$46.64K | GRANT | 10.60% | 297.02K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Dell Faulkingham | SVP, CCO | 36.82K | $2.16 | -$28.52K | GRANT | 26.87% | 173.84K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 28.94K | $2.17 | -$45.62K | GRANT | 10.51% | 304.24K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | David A Spellman | SVP, CFO AND TREASURER | 51.80K | $2.16 | -$17.69K | GRANT | 67.44% | 128.60K | Feb 28 - Mar 01 | View |
| Jan 05, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | -5.83K | $2.29 | -$13.34K | SELL | -14.99% | 33.07K | Jan 03 | View |
| Sep 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.04K | $2.83 | -$2.95K | SELL | -0.60% | 171.22K | Aug 31 | View |
| Jun 09, 2021 | Steven C Gilman | — | -4.57K | $3.32 | -$15.16K | SELL | -8.69% | 48.00K | Jun 07 | View |
| Apr 01, 2021 | Dell Faulkingham | SVP, CCO | -952.00 | $3.40 | -$3.24K | SELL | -0.69% | 137.03K | Apr 01 | View |
| Apr 01, 2021 | David A Spellman | SVP, CFO AND TREASURER | -790.00 | $3.40 | -$2.69K | SELL | -1.02% | 76.80K | Apr 01 | View |
| Apr 01, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -1.06K | $3.40 | -$3.60K | SELL | -0.39% | 272.30K | Apr 01 | View |
| Apr 01, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -1.21K | $3.40 | -$4.12K | SELL | -0.45% | 265.55K | Apr 01 | View |
| Apr 01, 2021 | John P Butler | CEO AND PRESIDENT | -4.11K | $3.40 | -$13.97K | SELL | -0.35% | 1.18M | Apr 01 | View |
| Apr 01, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.08K | $3.40 | -$3.68K | SELL | -0.63% | 170.76K | Apr 01 | View |
| Mar 02, 2021 | John P Butler | CEO AND PRESIDENT | 187.41K | $3.40 | -$169.77K | GRANT | 19.51% | 1.15M | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Dell Faulkingham | CCO | 55.25K | $3.40 | -$22.92K | GRANT | 75.10% | 128.82K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 47.72K | $3.40 | -$48.51K | GRANT | 22.15% | 263.17K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 47.45K | $3.40 | -$49.40K | GRANT | 22.85% | 255.11K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 62.44K | $3.40 | -$25.67K | GRANT | 63.07% | 161.44K | Feb 26 - Mar 01 | View |
| Jun 09, 2020 | Cynthia Smith | — | 9.13K | $12.10 | -$55.26K | GRANT OR AWARD | 31.82% | 37.83K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Steven C Gilman | — | 9.13K | $12.08 | -$55.17K | GRANT OR AWARD | 30.72% | 38.86K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Maxine Gowen | — | 9.13K | $12.05 | -$55.03K | GRANT OR AWARD | 60.89% | 24.13K | Jun 05 - Jun 08 | View |
| Jun 02, 2020 | Dell Faulkingham | — | -6.43K | $11.58 | -$74.41K | SELL | -8.03% | 73.57K | Jun 01 | View |
| Mar 02, 2020 | Michel Dahan | — | 58.03K | $8.70 | -$60.66K | GRANT OR AWARD | 39.49% | 204.96K | Feb 28 | View |
| Mar 02, 2020 | Nicole R Hadas | — | 54.95K | $8.70 | -$61.33K | GRANT OR AWARD | 34.82% | 212.76K | Feb 28 | View |
| Mar 02, 2020 | Jason Amello | — | 23.02K | $8.70 | -$60.69K | GRANT OR AWARD | 18.93% | 144.64K | Feb 28 | View |
| Mar 02, 2020 | Karen Tubridy | — | 26.55K | $8.70 | -$30.05K | GRANT OR AWARD | 45.66% | 84.68K | Feb 28 | View |
| Nov 22, 2019 | Steven C Gilman | — | 5.80K | $3.43 | $19.89K | BUY | 24.24% | 29.73K | Nov 20 | View |
| Nov 22, 2019 | Cynthia Smith | — | 15.00K | $3.52 | $52.80K | BUY | 109.49% | 28.70K | Nov 20 | View |
| Nov 22, 2019 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 27.00K | $3.58 | $96.66K | BUY | 270.00% | 37.00K | Nov 20 | View |
| Nov 21, 2019 | John P Butler | CEO AND PRESIDENT | 50.00K | $3.44 | $172.00K | BUY | 5.76% | 918.78K | Nov 20 | View |
| Nov 21, 2019 | Adrian Adams | — | 50.00K | $3.41 | $170.50K | BUY | 364.96% | 63.70K | Nov 20 | View |
| Feb 16, 2018 | Duane Nash | — | -1.00K | $14.62 | -$14.62K | SELL | -4.44% | 21.50K | Feb 15 | View |
| Oct 04, 2017 | Duane Nash | — | -1.19K | $19.64 | -$23.33K | SELL | -5.02% | 22.50K | Oct 02 | View |
| Oct 04, 2017 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -7.80K | $19.89 | -$155.19K | SELL | -7.12% | 101.80K | Oct 02 | View |
| Oct 04, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $19.64 | -$27.46K | SELL | -1.44% | 95.83K | Oct 02 | View |
| Oct 02, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -5.00K | $19.30 | -$96.50K | SELL | -4.89% | 97.22K | Sep 28 | View |
| Aug 17, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -5.00K | $15.00 | -$75.00K | SELL | -4.66% | 102.22K | Aug 15 | View |
| Jul 11, 2017 | Muneer Satter | DIRECTOR | 1.03M | $14.50 | $15.00M | BUY | 51.66% | 3.04M | Jul 05 | View |
| Jul 06, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $14.26 | -$19.95K | SELL | -1.29% | 107.22K | Jul 03 | View |
| Jul 06, 2017 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.55K | $14.26 | -$22.16K | SELL | -1.40% | 109.61K | Jul 03 | View |
| Jul 06, 2017 | Duane Nash | — | -990.00 | $14.27 | -$14.13K | SELL | -4.01% | 23.69K | Jul 03 | View |
| Apr 04, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $9.18 | -$12.86K | SELL | -1.27% | 108.62K | Apr 03 | View |
| Apr 04, 2017 | Duane Nash | — | -991.00 | $9.20 | -$9.12K | SELL | -3.86% | 24.68K | Apr 03 | View |
| Apr 04, 2017 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.56K | $9.18 | -$14.28K | SELL | -1.40% | 109.86K | Apr 03 | View |
| Jan 03, 2017 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.63K | $10.49 | -$17.09K | SELL | -2.26% | 70.52K | Jan 01 | View |
| Jan 03, 2017 | Duane Nash | — | -1.98K | $10.46 | -$20.71K | SELL | -7.16% | 25.67K | Jan 03 | View |
| Jan 03, 2017 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.81K | $10.49 | -$18.99K | SELL | -2.14% | 82.91K | Jan 01 | View |
| Oct 04, 2016 | Duane Nash | — | -1.98K | $8.96 | -$17.75K | SELL | -6.69% | 27.65K | Oct 03 | View |
| Oct 04, 2016 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $8.95 | -$12.55K | SELL | -1.90% | 72.15K | Oct 01 | View |
| Oct 04, 2016 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.56K | $8.95 | -$13.93K | SELL | -1.82% | 83.92K | Oct 01 | View |
| Jul 07, 2016 | Duane Nash | — | -1.98K | $7.48 | -$14.82K | SELL | -6.26% | 29.63K | Jul 06 | View |
| Jul 06, 2016 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $7.47 | -$10.47K | SELL | -1.87% | 73.55K | Jul 05 | View |
| Jul 06, 2016 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.56K | $7.47 | -$11.63K | SELL | -1.79% | 85.47K | Jul 05 | View |
| Apr 05, 2016 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.56K | $9.41 | -$14.64K | SELL | -1.79% | 85.53K | Apr 04 | View |
| Apr 05, 2016 | Michel Dahan | SVP, CHIEF BUSINESS OFFICER | -1.40K | $9.41 | -$13.18K | SELL | -1.83% | 74.96K | Apr 04 | View |
| Jan 06, 2016 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.81K | $12.28 | -$22.24K | SELL | -2.73% | 64.58K | Jan 04 | View |
| Oct 05, 2015 | Duane Nash | DIRECTOR | -996.00 | $8.65 | -$8.62K | SELL | -3.05% | 31.61K | Oct 02 | View |
| Oct 05, 2015 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.48K | $8.67 | -$12.86K | SELL | -2.22% | 65.26K | Oct 02 | View |
| Jul 06, 2015 | Duane Nash | DIRECTOR | -996.00 | $9.53 | -$9.49K | SELL | -2.96% | 32.60K | Jul 02 | View |
| Jul 06, 2015 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | -1.48K | $9.54 | -$14.16K | SELL | -2.18% | 66.74K | Jul 02 | View |
| Apr 22, 2015 | Muneer A Satter | DIRECTOR | 420.00K | $8.25 | $3.46M | BUY | 26.54% | 2.00M | Apr 22 | View |
| Apr 06, 2015 | Duane Nash | DIRECTOR | 984.00 | $9.30 | $9.78K | GRANT | 8.92% | 12.02K | Apr 01 - Apr 02 | View |
| Apr 06, 2015 | Nicole R Hadas | SVP, GENERAL COUNSEL, SEC. | 3.06K | $9.30 | $29.69K | GRANT | 4.18% | 76.09K | Apr 01 - Apr 02 | View |
| Jan 05, 2015 | Nicole R Hadas | VP GENERAL COUNSEL & SECRETARY | 2.82K | $11.55 | $33.18K | GRANT | 4.02% | 73.04K | Jan 01 - Jan 02 | View |
| Jan 05, 2015 | Duane Nash | DIRECTOR | 985.00 | $11.55 | $11.64K | GRANT | 8.33% | 12.81K | Jan 01 - Jan 02 | View |
| Dec 29, 2014 | John P Butler | CEO AND PRESIDENT | 1.00K | $11.57 | $11.57K | BUY | 2.11% | 48.35K | Dec 29 | View |
| Dec 29, 2014 | Duane Nash | DIRECTOR | 11.83K | $11.39 | $140.18K | GRANT | ∞ | 11.83K | Dec 23 - Dec 26 | View |
| Dec 22, 2014 | John P Butler | CEO AND PRESIDENT | 1.00K | $11.92 | $11.92K | BUY | 2.16% | 47.35K | Dec 22 | View |
| Dec 18, 2014 | John P Butler | CEO AND PRESIDENT | 1.00K | $11.34 | $11.34K | BUY | 2.21% | 46.35K | Dec 15 | View |
| Dec 02, 2014 | Ronald C. Renaud, Jr. | DIRECTOR | 5.00K | $11.92 | $59.59K | BUY | ∞ | 5.00K | Dec 02 | View |
| Dec 01, 2014 | Jason Amello | SVP, CFO & TREASURER | 1.00K | $13.22 | $13.22K | BUY | 25.00% | 5.00K | Nov 26 | View |
| Nov 26, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $13.18 | $65.90K | BUY | 0.32% | 1.58M | Nov 25 | View |
| Nov 25, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $13.88 | $69.40K | BUY | 0.32% | 1.58M | Nov 24 | View |
| Nov 24, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $14.73 | $73.65K | BUY | 0.32% | 1.57M | Nov 21 | View |
| Nov 21, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $14.70 | $73.50K | BUY | 0.32% | 1.57M | Nov 20 | View |
| Nov 20, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $14.85 | $74.25K | BUY | 0.32% | 1.56M | Nov 19 | View |
| Nov 19, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $13.84 | $69.20K | BUY | 0.32% | 1.56M | Nov 18 | View |
| Nov 18, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $12.94 | $64.70K | BUY | 0.32% | 1.55M | Nov 17 | View |
| Nov 17, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $11.91 | $59.55K | BUY | 0.32% | 1.55M | Nov 14 | View |
| Nov 14, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $11.56 | $57.80K | BUY | 0.33% | 1.54M | Nov 13 | View |
| Nov 14, 2014 | Maxine Gowen | DIRECTOR | 1.30K | $11.82 | $15.36K | BUY | ∞ | 1.30K | Nov 13 | View |
| Nov 13, 2014 | John P Butler | CEO AND PRESIDENT | 31.50K | $0.78 | $24.64K | BUY | 227.44% | 45.35K | Nov 11 - Nov 12 | View |
| Nov 13, 2014 | Muneer A Satter | DIRECTOR | 5.00K | $11.90 | $59.52K | BUY | 0.33% | 1.54M | Nov 12 | View |
| Mar 27, 2014 | Novartis Bioventures Ltd | 10% OWNER | 3.41M | $17.00 | $3.10M | BUY | ∞ | 3.41M | Mar 25 | View |
| Mar 27, 2014 | MICHAEL WYZGA | DIRECTOR | 1.50K | $17.00 | $25.50K | BUY | ∞ | 1.50K | Mar 25 | View |
| Mar 27, 2014 | Nicole R Hadas | SEE REMARKS | 3.50K | $17.00 | $59.50K | BUY | 4.82% | 76.12K | Mar 25 | View |
| Mar 27, 2014 | Muneer Satter | DIRECTOR | 1.53M | $17.00 | $1.55M | BUY | ∞ | 1.53M | Mar 25 | View |
| Mar 27, 2014 | John Butler | PRESIDENT AND CEO | 13.85K | $17.00 | $235.45K | BUY | ∞ | 13.85K | Mar 25 | View |
| Mar 27, 2014 | Jason Amello | SVP, CFO & TREASURER | 4.00K | $17.00 | $68.00K | BUY | ∞ | 4.00K | Mar 25 | View |
| Mar 26, 2014 | as Novo | 10% OWNER | 1.52M | $17.00 | $3.10M | BUY | ∞ | 1.52M | Mar 25 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
AKBA Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved